Nereus

Northsea Therapeutics

This company develops structurally engineered fatty acid drugs for patients with metabolic, inflammatory, and fibrotic diseases such as rare liver disorders.

Reax

This company develops chemical proteomic platform technologies to discover small molecule therapeutics for patients with cancer and immunological diseases.

Nectin Therapeutics

This company develops novel immunotherapeutic antibodies and antibody-drug conjugates for patients with solid and haematological cancers.

Biotheryx

The company develops protein degrader medicines for patients with cancer and inflammatory diseases.

Auron Therapeutics

This company develops small-molecule drugs using an AI-powered platform to treat patients with cancer and inflammatory diseases.

MyCural Therapeutics

This company develops small molecule drugs targeting the MYC oncoprotein to treat patients with aggressive, high-risk cancers.

Kymera Therapeutics

This biotechnology company develops small molecule medicines that degrade disease-causing proteins for patients with cancer and immune-inflammatory diseases.

Etheros

This company develops small molecule enzyme-mimetic drugs to prevent oxidative and inflammatory injury for patients with neurodegenerative and age-related conditions.